Fianlimab, CAS 2126132-98-5

Product Description: Fianlimab (REGN3767) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells and has anti-tumour activity[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Omid Hamid, et al. Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma.Meeting Abstract / 2021 ASCO Annual Meeting I.

CAS Number: 2126132-98-5

Molecular Weight: N/A

Compound Purity: 99.04

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: LAG-3

• SKU: MEXHY-P99617-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99617-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated